Literature DB >> 2424592

Neuropharmacology of S-adenosyl methionine.

M W Carney.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2424592     DOI: 10.1097/00002826-198606000-00002

Source DB:  PubMed          Journal:  Clin Neuropharmacol        ISSN: 0362-5664            Impact factor:   1.592


× No keyword cloud information.
  6 in total

Review 1.  Folates and psychiatric disorders. Clinical potential.

Authors:  R Crellin; T Bottiglieri; E H Reynolds
Journal:  Drugs       Date:  1993-05       Impact factor: 9.546

2.  L-3,4-dihydroxyphenylalanine (levodopa) lowers central nervous system S-adenosylmethionine concentrations in humans.

Authors:  R Surtees; K Hyland
Journal:  J Neurol Neurosurg Psychiatry       Date:  1990-07       Impact factor: 10.154

3.  Influence of S-adenosyl-L-methionine on chronic mild stress-induced anhedonia in castrated rats.

Authors:  A Benelli; M Filaferro; A Bertolini; S Genedani
Journal:  Br J Pharmacol       Date:  1999-06       Impact factor: 8.739

Review 4.  The use of diet and dietary components in the study of factors controlling affect in humans: a review.

Authors:  S N Young
Journal:  J Psychiatry Neurosci       Date:  1993-11       Impact factor: 6.186

5.  Pharmacokinetic-pharmacodynamic interaction between the COMT inhibitor tolcapone and single-dose levodopa.

Authors:  J Dingemanse; K Jorga; G Zürcher; M Schmitt; G Sedek; M Da Prada; P Van Brummelen
Journal:  Br J Clin Pharmacol       Date:  1995-09       Impact factor: 4.335

Review 6.  S-adenosyl-L-methionine. A review of its pharmacological properties and therapeutic potential in liver dysfunction and affective disorders in relation to its physiological role in cell metabolism.

Authors:  H A Friedel; K L Goa; P Benfield
Journal:  Drugs       Date:  1989-09       Impact factor: 9.546

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.